(Q48272058)

English

Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial

scientific article published on 11 April 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

0 references

1 reference

based on heuristic

inferred from title

8

object named as

Albert Dahan

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

author name string

Ingeborg Noppers

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Marieke Niesters

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Maarten Swartjes

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Martin Bauer

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Leon Aarts

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Natasja Geleijnse

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

René Mooren

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Elise Sarton

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

publication date

11 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

European Journal of Pain

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

15

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

942-949

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Ketamine and chronic pain--going the distance

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Intravenous infusion tests have limited utility for selecting long-term drug therapy in patients with chronic pain: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Neurophysiologic evidence for a central sensitization in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Short- and long-term efficacy of oral ketamine in eight chronic-pain patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Management of fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Predictive value of brain perfusion SPECT for ketamine response in hyperalgesic fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Follow-up of pain processing recovery after ketamine in hyperalgesic fibromyalgia patients using brain perfusion ECD-SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Ketamine for the treatment of chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Cognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Fibromyalgia and the complex regional pain syndrome: similarities in pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2011.03.008

21 January 2018

Identifiers

10.1016/J.EJPAIN.2011.03.008

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/21482474

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48272058&oldid=2193760302"